HEALWELL AI News Releases

HEALWELL Delivers 316% Revenue Growth and Increasing Customer Traction in Q1-2026

Thu, 07 May 2026 16:00:00 -0400

HEALWELL achieved quarterly revenue from continuing operations of $33.2 million in Q1-2026, an increase of 316% compared to revenue of $8.0 million generated in Q1-2025. Revenue growth in the quarter was largely driven by the Orion Health acquisition and organic growth of the Company's AI division. HEALWELL reported positive Adjusted EBITDA of $0.7 million in Q1-2026, compared to an Adjusted EBITDA loss of $2.3 million in Q1-2025, representing a year-over-year improvement of 132%. The...

HEALWELL AI Announces Conference Call for First Quarter 2026 Financial Results on May 8, 2026

Wed, 29 Apr 2026 03:15:00 -0400

HEALWELL AI to hold a conference call and simultaneous webcast on Friday, May 8, 2026, at 8:30 am ET (5:30 am PT). Toronto, Ontario--(Newsfile Corp. - April 29, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, is pleased to announce the Company will release its Fiscal First Quarter 2026 financial results for the period ended March 31, 2026, after market closing on Thursday, May 7, 2026....

HEALWELL AI Appoints Brad Porter to Board of Directors

Wed, 22 Apr 2026 03:15:00 -0400

HEALWELL appoints Brad Porter, Chief Commercial Officer of HEALWELL and CEO of Orion Health, to its Board of Directors to strengthen the Company's commercial and strategic expertise.Ian McCrae is stepping down from the Board of Directors to focus on other ventures following the successful integration of Orion Health into HEALWELL.Toronto, Ontario--(Newsfile Corp. - April 22, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence...

HEALWELL AI Delivers Record Revenue and First Year of Positive Adjusted EBITDA as Global AI Platform Strategy Takes Hold

Thu, 19 Mar 2026 07:00:00 -0400

Record revenue growth - HEALWELL achieved record annual revenue from continuing operations of approximately $103.8 million in fiscal 2025, an increase of 427% compared to the $19.7 million in fiscal 2024. The Company reported an IFRS net loss from continuing operations of $39.1 million in fiscal 2025, compared to a net loss of $24 million in fiscal 2024.First full year of positive Adjusted EBITDA - HEALWELL delivered Adjusted EBITDA of $2.3 million in fiscal 2025 compared to an Adjusted EBITDA...

HEALWELL AI Reaches 47 Peer-Reviewed Publications, Strengthening Its Scientific Moat for AI-Powered Real-World Clinical Evidence Generation

Thu, 12 Mar 2026 03:15:00 -0400

HEALWELL achieves its 47th total peer-reviewed publication validating its DARWEN™ AI across multiple disease areas and diverse patient populations.HEALWELL presented new scientific validation of DARWEN™ AI at the European Crohn's and Colitis Organisation (ECCO) meeting, with findings published in the Journal of Crohn's and Colitis(1).The study conducted with the U.S. affiliate of a large pharmaceutical partner, demonstrated how AI-enriched Canadian patient support program data can generate...

HEALWELL AI to Announce Fourth Quarter and Year End 2025 Financial Results on March 19, 2026

Mon, 09 Mar 2026 03:15:00 -0400

HEALWELL AI to hold a conference call and simultaneous webcast on Friday, March 20, 2026, at 8:30 am ET (5:30 am PT). Toronto, Ontario--(Newsfile Corp. - March 9, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, is pleased to announce the Company will release its Fiscal Fourth Quarter and Year End 2025 financial results for the period ended December 31, 2025, on Thursday, March 19, 2026....

HEALWELL AI Announces Multi-Million Dollar U.S. Health Information Exchange Contract and AI-Driven Pipeline Momentum

Thu, 05 Mar 2026 03:15:00 -0500

HEALWELL has signed a multi-million dollar, multi-year U.S.-based Health Information Exchange (HIE) software contract following a competitive procurement process.Strong momentum in all parts of the software pipeline including renewals, extensions, short listing and intent to award have advanced across core markets, reinforcing recurring data infrastructure revenue.Increasing participation in coordinated, enterprise-scale RFP bids leveraging Orion Health's global footprint.Toronto,...

HEALWELL to Participate in Upcoming TD Cowen, Scotiabank and ROTH Investor Conferences

Fri, 27 Feb 2026 07:00:00 -0500

46th Annual Health Care Conference on March 2-4, 2026, in Boston, MA29th Annual Scotiabank TMT Conference on March 3-4, 2026, in Toronto, ON38th Annual Roth Conference on March 22-24, 2026, in Dana Point, CAToronto, Ontario--(Newsfile Corp. - February 27, 2026) - HEALWELL AI Inc.(TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, is pleased to announce that Dr. Alexander Dobranowski, President of HEALWELL AI, will...

HEALWELL AI Expands Global Footprint with First AI Implementation in Middle East and Growing Enterprise Adoption Across Canada and the United States

Thu, 26 Feb 2026 03:15:00 -0500

HEALWELL has signed its first contract to deliver AI solutions in the Middle East to a major governmental health system, marking a key step in its global expansion. This new deployment to an existing Orion Health customer demonstrates the scalability of the DARWEN™ platform and reinforces the Company's commitment to improving patient care worldwide.HEALWELL is deploying SMART Identify, SMART Search, and SMART Summary across healthcare systems in Canada and the U.S., improving patient...

HEALWELL AI and WELL Health Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research

Thu, 19 Feb 2026 03:15:00 -0500

HEALWELL and WELL launch WELLTRUST™, a consent-first data governance and patient-identification platform enabling secure, compliant and scalable clinics data mobilization across WELL-operated clinics.WELLTRUST provides patients with clear, flexible, and revocable control over consent, while enabling researchers and clinicians to identify appropriate patients in an ethical, privacy-first way.The first commercial application combines WELL's expansive clinical footprint with HEALWELL's DARWEN™ AI...